DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis

Figure 5

Clinical relevance and prognostic analysis of DTL in BCa tissue microarray. (a) DTL expression was associated with the tumor stage of BCa. (b) Defining the optimum cut-off value using X-tile software. (c) High expression of DTL was associated with unfavorable prognosis. (d) Cox regression analysis represented that DTL was an independent prognostic factor for BCa.

(a)

(b)

(c)

(d)